CANADA LIFE ASSURANCE Co
InsurancePosition in PTCT — Ptc Therapeutics, Inc.
CIK 1046192
WINNIPEG, A2
Position in PTCT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$4,454,203
-$1,482,071 QoQ
Shares Held
65,378
-16.3% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CANADA LIFE ASSURANCE Co holds $291,124,718 across 78 Biotechnology names. PTCT ranks #15 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
192,144 | $85,799,981 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
78,886 | $60,950,479 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,255 | $18,943,961 | |
| 4 | INCY |
Incyte Corp
|
111,609 | $10,504,639 | |
| 5 | INSM |
INSMED Inc
|
53,890 | $8,812,092 | |
| 6 | ARGX |
Argenx SE
|
11,567 | $8,446,801 | |
| 7 | MRNA |
Moderna, Inc.
|
148,181 | $7,527,594 | |
| 8 | EXEL |
Exelixis, Inc.
|
167,451 | $7,181,973 |
All Filings in PTCT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,454,203 | 65,378 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,936,274 | 78,150 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,085,598 | 33,984 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,064,370 | 21,793 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,021,136 | 20,038 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $904,515 | 20,038 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $743,409 | 20,038 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $612,762 | 20,038 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $766,957 | 26,365 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $804,118 | 29,177 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $560,294 | 25,002 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $882,620 | 21,702 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $927,626 | 19,150 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $808,287 | 21,176 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $488,446 | 9,730 | Shares | Sole | 2022-11-01 | |
| 2022-03-31 | $125,734 | 3,370 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $134,227 | 3,370 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $125,397 | 3,370 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $142,449 | 3,370 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $198,017 | 4,182 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $255,227 | 4,182 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $195,508 | 4,182 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $212,194 | 4,182 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $155,822 | 3,493 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||